Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

v3.20.2
Stockholders' Deficit (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Equity [Abstract]      
Capital stock authorized 260,000,000    
Common stock, authorized 250,000,000   250,000,000
Common stock, par value (in dollars per share) $ 0.001   $ 0.001
Preferred stock, authorized 10,000,000   10,000,000
Preferred stock, par value (in dollars per share) $ 0.001   $ 0.001
Number of option exercised 100,000    
Proceeds from exercise of Option $ 5,400  
Share-based compensation expense 116,559    
Unrecognized compensation expense $ 306,282    
Weighted average period expected to recognized compensation expense (in years) 2 years 2 months 30 days    
Series A Preferred Stock Dividend Rate 10.00%    
Accrued dividends $ 1,076,874   $ 970,997